Onward Medical N.V.
EBR:ONWD.BR
5.84 (EUR) • At close February 19, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) EUR.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Omzet
| 0.077 | 0.532 | 2.148 | 1.399 | 0.8 | 0.554 | 0.474 |
| Kosten van de omzet
| 0.92 | 15.35 | 14.687 | 4.047 | 2.309 | 0.838 | 1.041 |
| Brutowinst
| -0.843 | -14.818 | -12.539 | -2.648 | -1.509 | -0.284 | -0.567 |
| Brutowinstmarge
| -10.948 | -27.853 | -5.838 | -1.893 | -1.886 | -0.513 | -1.196 |
| Onderzoek- en ontwikkelingskosten
| 12.442 | 13.841 | 13.138 | 7.932 | 5.823 | 5.356 | 4.722 |
| Algemene en administratieve kosten
| 0 | 11.327 | 8.072 | 6.241 | 2.671 | 2.247 | 1.246 |
| Verkoop- en marketingkosten
| 0 | 2.943 | 1.951 | 1.516 | 0.394 | 0.261 | 0.098 |
| Verkoop-, algemene en administratieve kosten
| 23.239 | 15.734 | 10.023 | 7.757 | 3.065 | 2.508 | 1.344 |
| Overige kosten
| 0 | -8.93 | 7.318 | 8.796 | 4.316 | 2.07 | 1.298 |
| Bedrijfskosten
| 35.681 | 20.645 | 17.341 | 24.485 | 13.204 | 9.934 | 7.364 |
| Bedrijfsresultaat
| -36.524 | -35.463 | -32.028 | -28.532 | -15.512 | -10.772 | -8.405 |
| Bedrijfsresultaat ratio
| -474.338 | -66.66 | -14.911 | -20.395 | -19.39 | -19.444 | -17.732 |
| Totaal overige inkomsten en kosten netto
| 0.759 | -0.611 | -1.51 | -5.713 | -4.482 | -2.672 | -1.489 |
| Inkomen voor belasting
| -35.765 | -36.074 | -33.538 | -34.245 | -19.994 | -13.444 | -9.894 |
| Inkomen voor belasting ratio
| -464.481 | -67.808 | -15.614 | -24.478 | -24.993 | -24.267 | -20.873 |
| Belastingkosten
| -0.04 | 0.107 | -0.766 | 0.069 | 0.02 | 0.039 | 0.018 |
| Nettowinst
| -35.725 | -36.181 | -32.772 | -34.314 | -20.014 | -13.483 | -9.912 |
| Nettowinstmarge
| -463.961 | -68.009 | -15.257 | -24.528 | -25.018 | -24.338 | -20.911 |
| WPA (Winst Per Aandeel)
| -0.8 | -1.2 | -1.09 | -1.14 | -0.96 | -0.65 | -0.48 |
| Verwaterde WPA
| -0.8 | -1.2 | -1.09 | -1.14 | -0.96 | -0.65 | -0.48 |
| EBITDA
| -32.868 | -35.234 | -31.255 | -28.302 | -15.293 | -10.54 | -8.173 |
| EBITDA ratio
| -426.857 | -66.229 | -14.551 | -20.23 | -19.116 | -19.025 | -17.243 |